140 related articles for article (PubMed ID: 20480804)
21. [Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].
Neye H
Pharm Unserer Zeit; 2002; 31(3):264-70. PubMed ID: 12071123
[No Abstract] [Full Text] [Related]
22. New and emerging treatments in dermatology: acne.
Katsambas A; Dessinioti C
Dermatol Ther; 2008; 21(2):86-95. PubMed ID: 18394082
[TBL] [Abstract][Full Text] [Related]
23. Spironolactone and cimetidine in treatment of acne.
Hatwal A; Bhatt RP; Agrawal JK; Singh G; Bajpai HS
Acta Derm Venereol; 1988; 68(1):84-7. PubMed ID: 2449021
[TBL] [Abstract][Full Text] [Related]
24. Hormonal therapy for acne.
George R; Clarke S; Thiboutot D
Semin Cutan Med Surg; 2008 Sep; 27(3):188-96. PubMed ID: 18786497
[TBL] [Abstract][Full Text] [Related]
25. Effects and side-effects of spironolactone therapy in women with acne.
Yemisci A; Gorgulu A; Piskin S
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):163-6. PubMed ID: 15752283
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone.
Krunic A; Ciurea A; Scheman A
J Am Acad Dermatol; 2008 Jan; 58(1):60-2. PubMed ID: 17964689
[TBL] [Abstract][Full Text] [Related]
27. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
Svendsen PF; Nilas L; Nørgaard K; Madsbad S
Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
[TBL] [Abstract][Full Text] [Related]
28. Metformin in adolescents with polycystic ovary syndrome: opposed.
Trent M
J Pediatr Adolesc Gynecol; 2002 Apr; 15(2):111-4. PubMed ID: 12066790
[No Abstract] [Full Text] [Related]
29. [Effect of aldosterone antagonism in heart failure: pharmacotherapeutic options].
Diercks GF; Overdiek JW; van Veldhuisen DJ
Ned Tijdschr Geneeskd; 2001 Feb; 145(5):204-8. PubMed ID: 11219145
[TBL] [Abstract][Full Text] [Related]
30. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
31. Hormonal therapy for acne: why not as first line therapy? facts and controversies.
Katsambas AD; Dessinioti C
Clin Dermatol; 2010; 28(1):17-23. PubMed ID: 20082945
[TBL] [Abstract][Full Text] [Related]
32. New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.
Cruz CS; Cruz LS; Domingues GS; Souza CA
Expert Opin Drug Saf; 2005 Jul; 4(4):677-88. PubMed ID: 16011447
[TBL] [Abstract][Full Text] [Related]
33. Use of systemic agents in the treatment of acne vulgaris.
Johnson BA; Nunley JR
Am Fam Physician; 2000 Oct; 62(8):1823-30, 1835-6. PubMed ID: 11057839
[TBL] [Abstract][Full Text] [Related]
34. Unexpected survival from severe metformin-associated lactic acidosis.
Schure PJ; de Gooijer A; van Zanten AR
Neth J Med; 2003 Oct; 61(10):331-3. PubMed ID: 14708912
[TBL] [Abstract][Full Text] [Related]
35. A method to gain a sense of relative efficacy of acne medications that have not yet been studied.
Feldman SR; Fleischer AB
J Drugs Dermatol; 2007 Oct; 6(10):976. PubMed ID: 17966173
[No Abstract] [Full Text] [Related]
36. A new approach to comparing efficacy results from clinical trials of topical acne vulgaris treatments.
Bikowski J
J Drugs Dermatol; 2007 Jul; 6(7):688-92. PubMed ID: 17763591
[TBL] [Abstract][Full Text] [Related]
37. Acne. Myths and management issues.
Clearihan L
Aust Fam Physician; 2001 Nov; 30(11):1039-44. PubMed ID: 11759452
[TBL] [Abstract][Full Text] [Related]
38. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
Fuster D; Frey FJ; Ferrari P
Praxis (Bern 1994); 2000 Dec; 89(49):2073-6. PubMed ID: 11190849
[TBL] [Abstract][Full Text] [Related]
39. Pharmacotherapy of acne.
Degitz K; Ochsendorf F
Expert Opin Pharmacother; 2008 Apr; 9(6):955-71. PubMed ID: 18377339
[TBL] [Abstract][Full Text] [Related]
40. Azelaic acid--a new topical treatment for acne.
Drug Ther Bull; 1993 Jun; 31(13):50-2. PubMed ID: 8344141
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
